Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Brun

Showing results (211-220 of 226) with videos related to

Pageof 23
Sort By:
Annals of Intensive Care|July 9, 2013
Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation of antibiotic therapyJean-Pierre Quenot, Charles-Edouard Luyt, Nicolas Roche, et al.
Annals of Intensive Care|July 11, 2013
Role of biomarkers in the management of antibiotic therapy: an expert panel review: I - currently available biomarkers for clinical use in acute infectionsAnne-Marie Dupuy, François Philippart, Yves Péan, et al.
Blood|December 14, 2006
Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activitySilvia Ferrari, Friedrich Scheiflinger, Manfred Rieger, et al.
American Journal of Respiratory and Critical Care Medicine|March 26, 2013
Recombinant human activated protein C for adults with septic shock: a randomized controlled trialDjillali Annane, Jean-François Timsit, Bruno Megarbane, et al.
Lancet (London, England)|July 4, 2009
Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trialPatricia Jabre, Xavier Combes, Frederic Lapostolle, et al.
Archives of Internal Medicine|March 24, 2010
Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control programVincent Jarlier, David Trystram, Christian Brun-Buisson, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|December 4, 2023
Protocol for an international, multicentre, prospective, observational study of nosocomial pneumonia in intensive care units: the PneumoINSPIRE studyDespoina Koulenti, Apostolos Armaganidis, Kostoula Arvaniti, et al.
Intensive Care Medicine|August 22, 2018
Clinical spectrum and short-term outcome of adult patients with purpura fulminans: a French multicenter retrospective cohort studyDamien Contou, Romain Sonneville, Florence Canoui-Poitrine, et al.
The Lancet. Infectious Diseases|October 29, 2013
Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trialLennie P G Derde, Ben S Cooper, Herman Goossens, et al.
Intensive Care Medicine|December 7, 2007
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008R Phillip Dellinger, Mitchell M Levy, Jean M Carlet, et al.
Pageof 23

Showing results (211-220 of 226) with videos related to

Sort By:
Pageof 23
Annals of Intensive Care|July 9, 2013
Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation of antibiotic therapyJean-Pierre Quenot, Charles-Edouard Luyt, Nicolas Roche, et al.
Annals of Intensive Care|July 11, 2013
Role of biomarkers in the management of antibiotic therapy: an expert panel review: I - currently available biomarkers for clinical use in acute infectionsAnne-Marie Dupuy, François Philippart, Yves Péan, et al.
Blood|December 14, 2006
Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activitySilvia Ferrari, Friedrich Scheiflinger, Manfred Rieger, et al.
American Journal of Respiratory and Critical Care Medicine|March 26, 2013
Recombinant human activated protein C for adults with septic shock: a randomized controlled trialDjillali Annane, Jean-François Timsit, Bruno Megarbane, et al.
Lancet (London, England)|July 4, 2009
Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trialPatricia Jabre, Xavier Combes, Frederic Lapostolle, et al.
Archives of Internal Medicine|March 24, 2010
Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control programVincent Jarlier, David Trystram, Christian Brun-Buisson, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|December 4, 2023
Protocol for an international, multicentre, prospective, observational study of nosocomial pneumonia in intensive care units: the PneumoINSPIRE studyDespoina Koulenti, Apostolos Armaganidis, Kostoula Arvaniti, et al.
Intensive Care Medicine|August 22, 2018
Clinical spectrum and short-term outcome of adult patients with purpura fulminans: a French multicenter retrospective cohort studyDamien Contou, Romain Sonneville, Florence Canoui-Poitrine, et al.
The Lancet. Infectious Diseases|October 29, 2013
Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trialLennie P G Derde, Ben S Cooper, Herman Goossens, et al.
Intensive Care Medicine|December 7, 2007
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008R Phillip Dellinger, Mitchell M Levy, Jean M Carlet, et al.
Pageof 23